| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2870960 | The Annals of Thoracic Surgery | 2016 | 8 Pages |
Abstract
CKD stages 3b to 5 increases the risk of mortality after TAVI and SAVR. In this subset of patients, SAVR was associated with somewhat better early and late survival. The risk of acute kidney injury was higher after SAVR. These findings suggest that CKD stages 3b to 5 does not contraindicate SAVR. Strategies to prevent severe acute kidney injury should be implemented with either SAVR or TAVI.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Paola MS, Claudio MD, Fabrizio MD, Stefano MS, Fausto MD, Marco MD, Francesco MD, Marco MD, Antonio MD, Corrado MD, Francesco MD, Gennaro MD, Claudio MD, Danilo MS, Fulvia MS, OBSERVANT Research Group OBSERVANT Research Group,